Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             40 results found
no title author magazine year volume issue page(s) type
1 A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside Chapman, Paul B
 2004
 22 21-22 p. 2904-2909
6 p.
 article
2 Breaking new ground—are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Clements, C.J
 2004
 22 21-22 p. 2822-2826
5 p.
 article
3 CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques Klinman, Dennis M.
 2004
 22 21-22 p. 2881-2886
6 p.
 article
4 Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis Cloeckaert, Axel
 2004
 22 21-22 p. 2827-2835
9 p.
 article
5 Development of an in vitro-based potency assay for anthrax vaccine Little, S.F.
 2004
 22 21-22 p. 2843-2852
10 p.
 article
6 Development of antibodies against pneumococcal proteins α-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media Adrian, Peter V
 2004
 22 21-22 p. 2737-2742
6 p.
 article
7 Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women Fife, Kenneth H
 2004
 22 21-22 p. 2943-2952
10 p.
 article
8 Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine Brown, Darron R
 2004
 22 21-22 p. 2936-2942
7 p.
 article
9 Editorial Board/Aims and Scope 2004
 22 21-22 p. IFC-
1 p.
 article
10 Effect of chemical adjuvants on DNA vaccination Jin, Huali
 2004
 22 21-22 p. 2925-2935
11 p.
 article
11 Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7) Davidson, E.J
 2004
 22 21-22 p. 2722-2729
8 p.
 article
12 Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles Mollenkopf, Hans-Joachim
 2004
 22 21-22 p. 2690-2695
6 p.
 article
13 Estimating influenza-related hospital admissions in older people from GP consultation data Scuffham, Paul A.
 2004
 22 21-22 p. 2853-2862
10 p.
 article
14 Human airway epithelial cells present antigen to influenza virus-specific CD8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX® Rimmelzwaan, G.F.
 2004
 22 21-22 p. 2769-2775
7 p.
 article
15 Identification and assessment of new vaccine candidates for group A streptococcal infections McMillan, David J
 2004
 22 21-22 p. 2783-2790
8 p.
 article
16 Identification of adjuvants that enhance the therapeutic antibody response to host IgE Johansson, Jeannette
 2004
 22 21-22 p. 2873-2880
8 p.
 article
17 Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies Peng, Xuanxian
 2004
 22 21-22 p. 2750-2756
7 p.
 article
18 Immunization with PfEMP1-DBL1α generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes Chen, Qijun
 2004
 22 21-22 p. 2701-2712
12 p.
 article
19 Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein Kaur, Rupinderjeet
 2004
 22 21-22 p. 2776-2782
7 p.
 article
20 Influenza and pneumococcal vaccination of the elderly in Taiwan Chen, Yeong-Hwang
 2004
 22 21-22 p. 2806-2811
6 p.
 article
21 Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine Marsden, Catherine J.
 2004
 22 21-22 p. 2800-2805
6 p.
 article
22 Letter to the Editor Desauziers, Eric
 2004
 22 21-22 p. 2681-2684
4 p.
 article
23 Limited infection upon human exposure to a recombinant raccoon pox vaccine vector Rocke, Tonie E
 2004
 22 21-22 p. 2757-2760
4 p.
 article
24 Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response Flanagan, Kenneth
 2004
 22 21-22 p. 2894-2903
10 p.
 article
25 Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine Huebner, Robin E
 2004
 22 21-22 p. 2696-2700
5 p.
 article
26 Maturation of dendritic cells by bacterial immunomodulators Spisek, Radek
 2004
 22 21-22 p. 2761-2768
8 p.
 article
27 Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application Caputo, Antonella
 2004
 22 21-22 p. 2910-2924
15 p.
 article
28 Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vandermeulen, Corinne
 2004
 22 21-22 p. 2713-2716
4 p.
 article
29 Persistence of protective immunity following vaccination against tick-borne encephalitis—longer than expected? Rendi-Wagner, P
 2004
 22 21-22 p. 2743-2749
7 p.
 article
30 Pertussis vaccination strategies for neonates—an exploratory cost-effectiveness analysis Scuffham, P.A.
 2004
 22 21-22 p. 2953-2964
12 p.
 article
31 Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries Basuni, Ashraf A.
 2004
 22 21-22 p. 2791-2799
9 p.
 article
32 Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells Reuter, Thorsten
 2004
 22 21-22 p. 2686-2689
4 p.
 article
33 Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice Wüest, Thomas
 2004
 22 21-22 p. 2717-2721
5 p.
 article
34 Reply to Letter to the Editor Jefferson, Tom
 2004
 22 21-22 p. 2685-
1 p.
 article
35 Report on a WHO Consultation on the characterisation of BCG strains, Imperial College, London 15–16 December 2003 Corbel, M.J
 2004
 22 21-22 p. 2675-2680
6 p.
 article
36 Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants Vesikari, T
 2004
 22 21-22 p. 2836-2842
7 p.
 article
37 Separation and characterization of adjuvant oligosaccharide oleate ester derived from product mixture of mannitol-oleic acid esterification Oda, Kenji
 2004
 22 21-22 p. 2812-2821
10 p.
 article
38 Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice Stertman, Linda
 2004
 22 21-22 p. 2863-2872
10 p.
 article
39 The incidence of varicella in southern Taiwan: a life table method estimation among susceptible population Tan, H.F
 2004
 22 21-22 p. 2730-2736
7 p.
 article
40 Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection Okamoto, Shigefumi
 2004
 22 21-22 p. 2887-2893
7 p.
 article
                             40 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands